-
AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status
Mar 10, 2025, 14:00 PM -
Sentence-Level Abstract Section Classification in HEOR Literature using a Biomedical Language Model
Mar 10, 2025, 14:00 PM -
Health Insurance Use Among Young Pharmacists in Nigeria
Mar 10, 2025, 14:00 PM -
A Targeted Review of the Application of Discrete Event Simulation Modeling in CDA-AMC Assessments
Mar 10, 2025, 14:00 PM -
Characteristics Correlated with Limited Physical Functioning in US Adults with Arthritis: A Cross-Sectional Database Analysis of the Medical Expenditure Panel Survey.
Mar 10, 2025, 14:00 PM -
Trends of Mortality by Ulcer Decubitus in Colombia, 1998 - 2022
Mar 10, 2025, 14:00 PM -
Impact of Pharmacist Managed Pulmonary Arterial Hypertension Program on TYVASO Adherence
Mar 10, 2025, 14:00 PM -
Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach
Mar 10, 2025, 14:00 PM -
Which Strategy is More Effective in Patients with Rheumatoid Arthritis (RA) and Metotrexate Failure: Adding Leflunomide or TNFi?
Mar 10, 2025, 14:00 PM -
Patient Value Assessment Using a Unified Measure Based on Data Envelopment Analysis: A Case Study
Mar 10, 2025, 14:00 PM -
The Use of Social Media Listening to Collect Oncology-Specific Patient Experience Data: A Scoping Review
Mar 10, 2025, 14:00 PM -
Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years
Mar 10, 2025, 14:00 PM -
Development of New Patient Reported Outcome (PRO) Conceptual Models for Treatment Adherence and Satisfaction in People with HIV
Mar 10, 2025, 14:00 PM -
HTA Assessments for Multipurpose Contrast Agents: Insights and Solutions to Formal HTA Challenges
Mar 10, 2025, 14:00 PM -
The Utilization of Qualitative Evidence Synthesis in Brazil’s Public Health System: A Qualitative Analysis
Mar 10, 2025, 14:00 PM -
Taletrectinib vs Entrectinib in ROS1-Positive (ROS1+) Non-Small Cell Lung Cancer (NSCLC): A Matching-Adjusted Indirect Comparison (MAIC)
Mar 10, 2025, 14:00 PM -
Cost Savings With Treosulfan and Fludarabine (Treo/Flu) vs. Busulfan and Fludarabine (Bu2/Flu) Conditioning Regimen in Patients Undergoing Allogeneic HSCT for Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Mar 10, 2025, 14:00 PM -
An Open-Source LLM Framework For Transparent Data Extraction From Research Papers
Mar 10, 2025, 14:00 PM -
type 2 Inflammation and Exacerbator Profiles in COPD Patients: Real-World Data From a Brazilian Specialized Center
Mar 10, 2025, 14:00 PM -
A Conceptual Model of Multiple Myeloma Symptoms and Impacts, and A Characterization of Pain Among Patients Living With Relapsed/Refractory Multiple Myeloma
Mar 10, 2025, 14:00 PM
